72 results
Therapeutic Indications for the Anticonvulsant Agents

#Anticonvulsant #Antiseizure #Medications #Pharmacology #Table #Neurology #Epilepsy #Management
Anticonvulsant Agents ... #Antiseizure #Medications ... #Pharmacology # ... Table #Neurology ... #Epilepsy #Management
REBEL Review 4 & 5: Paralytic & Vasopressor Dosing 

Paralytic Agents:
 - Succinylcholine (Depolarizing Agent)
& Vasopressor Dosing ... Paralytic Agents ... resuscitation #table ... #criticalcare #pharmacology ... #dosing #medications
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Non-Opioid Analgesics - Agents ... and Dosing #Management ... #Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Muscle Relaxants - Agents ... and Dosing #Management ... #Pain #Pharmacology ... Relaxers #Relaxants #Medications ... #Table #PAMI
Pharmacologic prophylaxis of VTE in selected clinical scenarios.

Enoxaparin 
Dalteparin 
Fondaparinux 
Dabigatran 
Unfractionated Heparin
Warfarin 
Aspirin 

#prophylaxis #VTE
Pharmacologic prophylaxis ... prophylaxis #VTE #DVT #dosing ... #Medications #management ... #indications #pharmacology ... #table
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Neuropathic Pain Medications ... : Agent, Initiation ... #Neuropathic #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Distribution, Agents ... and Dosing Table ... #Pain #Pharmacology ... Nerve #Blocks #Medications ... #Table #PAMI
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents ... Diabetes #Diabetic #Medications ... #Pharmacology # ... Dosing #Dosing # ... Impairment #CKD #Table
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Overview of Treatment Agents ... 4/11/2020 #Drugs ... #Medications #Treatment ... #COVID19 #Pharmacology ... #Table #Management
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
of Antianginal Drugs ... #Antianginal #Medications ... #Cardiology #Pharmacology ... #Management #Therapy ... #Table #Overview